Collaboration Between Industry and Outside Researchers Posted on October 19, 2007 Jeffrey Jonas (bio) talks about industry and investigator-initiated studies.

Pharmaceutical companies work with outside researchers in a number of ways. One is, and depending on the stage of the trial, we frequently work with outside researchers to conduct our Phase II and Phase III trials. And in fact, we need to, because we have to enroll patients, and those patients have to be at the researchers’ sites. And we work with a range of researchers from people who are in private practice, to academic researchers.

Then there are groups of studies that are funded by companies that are investigator-initiated trials. And every company has a different approach to this. In our case, we don’t maintain any control over these trials once the grant is approved. And those are trials that are done at the discretion and under the supervision of the external researcher. These are typically smaller trials, often exploratory in nature or trials designed to answer an interesting scientific question.

« Back to Article